Compass Therapeutics adopts new bylaws establishing exclusive federal forum for Securities Act claims

Compass Therapeutics, Inc.

Board approved Second Amended and Restated Bylaws effective June 22, 2026.
New bylaws require Securities Act of 1933 claims to be brought in U.S. District Courts for Delaware or Massachusetts.
Previous bylaws from July 17, 2020 restated in entirety.
Change is procedural; no impact on operations or financials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.